Inflammation and cancer: back to Virchow?

Parkin, 1999

Gulumian, 1999, The role of oxidative stress in diseases caused by mineral dusts and fibres: current status and future of prophylaxis and treatment, Mol Cell Biochem, 196, 69, 10.1023/A:1006918212866

Ekbom, 1990, Ulcerative colitis and colorectal cancer, N Engl J Med, 323, 1228, 10.1056/NEJM199011013231802

Negus, 1997, Quantitative assessment of the leucocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines, Am J Pathol, 150, 1723

Mantovani, 1992, The origin and function of tumor-associated macrophages, Immunol Today, 13, 265, 10.1016/0167-5699(92)90008-U

Mantovani, 1992, Cytokine regulation of endothelial cell function, FASEB J, 6, 2591, 10.1096/fasebj.6.8.1592209

Coussens, 2000, MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis, Cell, 103, 481, 10.1016/S0092-8674(00)00139-2

Allavena, 2000, The chemokine receptor switch paradigm and dendritric cell migration: its significance in tumor tissues, Immunol Rev, 177, 141, 10.1034/j.1600-065X.2000.17714.x

van den Berg, 1999, High expression of the CC chemokine TARC in Reed-Sternberg cells: a possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma, Am J Pathol, 154, 1685, 10.1016/S0002-9440(10)65424-7

Mizoguchi, 1992, Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice, Science, 258, 1795, 10.1126/science.1465616

Dvorak, 1986, Tumors: wounds that do not heal, N Engl J Med, 315, 1650, 10.1056/NEJM198612253152606

Pinedo, 1998, Involvement of platelets in tumour angiogenesis?, Lancet, 352, 1775, 10.1016/S0140-6736(98)05095-8

Burke, 1996, A cytokine profile of normal and malignant ovary, Cytokine, 8, 578, 10.1006/cyto.1996.0077

Koong, 2000, Candidate genes for hypoxic tumor phenotype, Cancer Res, 60, 883

Kollias, 1999, On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease, Immunol Rev, 169, 175, 10.1111/j.1600-065X.1999.tb01315.x

Lejeune, 1998, Clinical applications of TNF-a in cancer, Curr Opin Immunol, 10, 573, 10.1016/S0952-7915(98)80226-4

Naylor, 1993, Tumor necrosis factor and its receptors in human ovarian cancer, J Clin Invest, 91, 2194, 10.1172/JCI116446

Leek, 1998, Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma, Br J Cancer, 77, 2246, 10.1038/bjc.1998.373

Warzocha, 1997, Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients, J Clin Oncol, 15, 499, 10.1200/JCO.1997.15.2.499

Malik, 1989, Paradoxical, effects of tumour necrosids factor in experimental ovarian cancer, Int J Cancer, 44, 918, 10.1002/ijc.2910440529

Malik, 1990, Cells secreting tumour necrosis factor show enhanced metastasis in nude mice, Eur J Cancer, 26, 1031, 10.1016/0277-5379(90)90044-T

Roberts, 1999, Cytokines in non-genotoxic hepatocarcinogenesis, Carcinogenesis, 20, 1397, 10.1093/carcin/20.8.1397

Moore, 1999, Tumour necrosis factor-a deficient mice are resistant to skin carcinogenesis, Nat Med, 5, 828, 10.1038/10552

Robertson, 1996, Inhibition of pro-inflammatory cytokine gene expression and papilloma growth during murine multistage carcinogenesis by pentoxifylline, Carcinogenesis, 17, 1719, 10.1093/carcin/17.8.1719

Vidal-Vanaclocha, 2000, IL-18 regulates IL-1b-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1, PNAS, 97, 734, 10.1073/pnas.97.2.734

Tricot, 2000, New insights into role of microenvironment in multiple myeloma, Lancet, 355, 248, 10.1016/S0140-6736(00)00019-2

Negus, 1995, The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer, J Clin Invest, 95, 2391, 10.1172/JCI117933

Luboshits, 1999, Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma, Cancer Res, 59, 4681

Cossman, 1999, Reed-Sternberg cell genome expression supports a B-cell lineage, Blood, 94, 411, 10.1182/blood.V94.2.411

Hanghnegahdar, 2000, The tumorigenic and angiogenic effects of MGSSA/GRO proteins in melanoma, J Leukoc Biol, 67, 53, 10.1002/jlb.67.1.53

Medrano, 1993, Chronic growth stimulation of human adult melanocytes by inflammatory mediators in vitro: implications for nevus formation and initial steps in melanocyte oncogenesis, Proc Natl Acad Sci, 90, 1790, 10.1073/pnas.90.5.1790

Mazzucchelli, 1999, BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma, J Clin Invest, 104, 49, 10.1172/JCI7830

Sica, 2000, Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma, J Immunol, 164, 733, 10.4049/jimmunol.164.2.733

Venkatakrishnan, 2000, Chemokine receptors CXCR-1/2 activate mitogen activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells, J Biol Chem, 275, 6868, 10.1074/jbc.275.10.6868

Wang, 1998, Purification and identification of chemokines potenetially involved in kidney-specific metastasis by a murine lymphoma variant: induction of migration and NFkB activation, Int J Cancer, 75, 900, 10.1002/(SICI)1097-0215(19980316)75:6<900::AID-IJC13>3.0.CO;2-6

Komori, 1993, Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation, Cancer Res, 53, 1982

Jaiswal, 2000, Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism, Cancer Res, 60, 184

Hudson, 1999, A proinflammatory cytokine inhibits p53 tumor suppressor activity, J Exp Med, 190, 1375, 10.1084/jem.190.10.1375

El-Omar, 2000, Interleukin-1 polymorphisms associated with increased risk of gastric cancer, Nature, 404, 398, 10.1038/35006081

O'Byrne, 2000, The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease, Eur J Cancer, 36, 151, 10.1016/S0959-8049(99)00241-5

Leek, 1999, Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast, Br J Cancer, 79, 991, 10.1038/sj.bjc.6690158

Keane, 1999, vol 72, 86

Opdenakker, 1992, Chemotactic factors, passive invasion and metastasis of cancer cells, Immunol Today, 13, 463, 10.1016/0167-5699(92)90079-M

Martin Padura, 1991, Heterogeneity in human melanoma cell adhesion to cytokine activated endothelia cells correlates with VLA-4 expression, Cancer Res, 51, 2239

Korner H. Cretney, 2000, Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype, J Exp Med, 191, 89, 10.1084/jem.191.1.89

Goerdt, 1999, Other function, other genes: alternative activation of antigen-presenting cells, Immunity, 10, 137, 10.1016/S1074-7613(00)80014-X

Sica, 2000, Autocrine production of IL-10 mediates defective IL-12 production and NF-κB activation of tumor-associated macrophages, J Immunol, 164, 762, 10.4049/jimmunol.164.2.762

Gu, 2000, Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1, Nature, 404, 407, 10.1038/35006097

Sozzani, 1998, The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant, Blood, 92, 4036, 10.1182/blood.V92.11.4036

Endres, 1999, The Kaposi's sarcoma-related herpes virus (KSHV)-encoded chemokine vMIP-1 is a specific agonist for the CC receptor (CCR)8, J Exp Med, 189, 1993, 10.1084/jem.189.12.1993

Gambacorti-Passerini, 2000, Role of alpha 1 acidic glycoprotein in the in vivo resistance of human BCR-ABL (+) leukemic cells to the abl inhibitor STI571, JNCI, 92, 1641, 10.1093/jnci/92.20.1641

Snyderman, 1984, Immunosuppressive activity in the retroviral envelope protein P15E and its possible relationship to neoplasia, Immunol Today, 5, 240, 10.1016/0167-5699(84)90097-5

Rutledge, 1995, High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens, J Immunol, 155, 4838, 10.4049/jimmunol.155.10.4838

Warzocha, 1998, Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome, Blood, 91, 3574, 10.1182/blood.V91.10.3574

Oh, 2000, Frequent genotype changes at −308 and 488 regions of the tumor necrosis factor-alpha (TNF-alpha) gene in patients with prostate cancer, J Urol, 163, 1584, 10.1016/S0022-5347(05)67683-5

Barber, 2000, A polymorphism of the interleukin-1β gene influences survival in pancreatic cancer, Br J Cancer, 83, 1443, 10.1054/bjoc.2000.1479

Maini, 2000, Anti-cytokine therapy for rheumatoid arthritis, Annu Rev Med, 51, 207, 10.1146/annurev.med.51.1.207

Tisdale, 1997, Biology of cachexia, JNCI, 89, 1763, 10.1093/jnci/89.23.1763

Singhal, 1999, Antitumor activity of thalidomide in refractory multiple myeloma, N Engl J Med, 341, 1565, 10.1056/NEJM199911183412102

Peng, 1997, Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells, Cancer Res, 57, 4849

Bataille, 1995, Biologic effects of antiinterleukin-6 murine monoclonal antibody in advanced multiple myeloma, Blood, 86, 685, 10.1182/blood.V86.2.685.bloodjournal862685

Thun, 1993, Aspirin use and risk of fatal cancer, Cancer Res, 53, 1322

Langman, 2000, Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database, BMJ, 320, 1642, 10.1136/bmj.320.7250.1642

Reddy, 1996, Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis, Cancer Res, 56, 4566

Steinbach, 2000, The effect of celecoxib a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis, N Engl J Med, 342, 1946, 10.1056/NEJM200006293422603